EUCTR2008-005912-41-GB进行中（未招募）1 期
Temocillin use in Complicated Urinary Tract Infections due to ESBL producing and AmpC hyperproducing Enterobacteriaceae in United Kingdom - TEA trial
Belpharma SA/NV0 个研究点目标入组 50 人开始时间: 2008年10月31日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patient presenting a complicated urinary tract infection (i.e. acute pyelonephritis, UTI in men, or UTI associated with obstruction, foreign bodies, or urologic abnormalities) due to a confirmed ESBL producing or AmpC hyperproducing Enterobacteriaceae susceptible to temocillin requiring parenteral antimicrobial therapy
- •community or hospital acquired infecting bacteria
- •signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •patients infected with a strain resistant to temocillin (if included at first, then the patient will be kept in the ITT group, therapy will be switched and the patient will be followed for the same time as other enrolled patients).
- •patients having received an active antimicrobial therapy during the 48h before the beginning of temocillin treatment (i.e. having received an antibiotic to which the infecting bacteria is susceptible) except temocillin (i.e. if the patient has been treated empirically with temocillin, they will not be excluded)
- •patients presenting with another site of infection than urinary (except onset of bacteremia from urinary tract origin) due to Gram negative bacteria
- •patients needing concomitant antimicrobial therapy with the exception of benzylpenicillin
- •uncomplicated cystitis
- •complete obstruction of the urinary tract
- •prostatitis
- •perinephretic or intrarenal abscesses
- •renal transplant
- •children (up to 18 years old)
- •pregnancy or lactation
- •chronically dialyzed patients
- •immunocompromising therapy or illness
- •known allergy to penicillin
研究者
相似试验
撤回
4 期
Temocillin Use in Complicated Urinary Tract Infections Due to Extended Spectrum Beta-Lactamases (ESBL)/AmpC EnterobacteriaceaeUrinary Tract InfectionNCT01543347Belpharma s.a.
Unknown
4 期
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing EnterobacteriaceaeUrinary Tract InfectionsNCT02681263University Hospital, Grenoble25
进行中（未招募）
1 期
Temocilin vs meropenem for the treatment of infections due to EnterobacterialesInfections due to EnterobacteriaceaeMedDRA version: 20.1Level: PTClassification code: 10060945Term: Bacterial infection Class: 100000004862CTIS2023-508440-21-00Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla334
进行中（未招募）
不适用
Temocillin use in intensive care units:A Pharmacokinetic study of 6g per day in conventional administration vs. continuous infusioPatients will be eligible for participation in the study if they :1.are hospitalized in an intensive care unit2.have an abdominal or a pulmonary infectionMedDRA version: 9.1Level: PTClassification code 10056519Term: Abdominal infectionMedDRA version: 9.1Level: LLTClassification code 10052110Term: Bronchopulmonary infectionEUCTR2007-003223-20-BECliniques Universitaires St Luc - UC
进行中（未招募）
Unknown
SW Government-Sponsored Clinical Trial: Management of Urinary Tract Infections by Community Pharmacistsrinary tract infectionsUrinary tract infectionsRenal and Urogenital - Other renal and urogenital disordersPublic Health - Health service researchACTRN12623000882628The University of Newcastle18,143